Augmentin and Cellulitis orbital - a phase IV clinical study of FDA data

Summary:

Cellulitis orbital is reported as a side effect among people who take Augmentin (amoxicillin; clavulanate potassium), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Methotrexate, and have Neoplasm malignant.

The phase IV clinical study analyzes which people have Cellulitis orbital when taking Augmentin. It is created by eHealthMe based on reports of 41,293 people who have side effects when taking Augmentin from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Cellulitis orbital?

Cellulitis orbital (acute spread of infection into the eye socket) is found to be associated with 97 drugs and 193 conditions by eHealthMe. Check the latest studies of Cellulitis orbital.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

41,293 people reported to have side effects when taking Augmentin.
Among them, 14 people (0.03%) have Cellulitis orbital.

Could Augmentin cause Cellulitis orbital?

Among these 14 people:

How long have people been on Augmentin when they have Cellulitis orbital? *

What is the gender of people who have Cellulitis orbital when taking Augmentin? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Cellulitis orbital when taking Augmentin? *

What are other drugs people take besides Augmentin? *

What are other side effects people have besides Cellulitis orbital? *

Eye Swelling: 10 people, 71.43%
Eye Allergy: 10 people, 71.43%
Asthma: 10 people, 71.43%
Chest Pain: 10 people, 71.43%
Herpes Zoster: 10 people, 71.43%
Indigestion: 9 people, 64.29%
Metastases To Spine (cancer spreads to spine): 9 people, 64.29%
Metastases To Pelvis (cancer spreads to pelvis): 9 people, 64.29%
Metastases To Lung (cancer spreads to lung): 9 people, 64.29%
Metastases To Bone (cancer spreads to bone): 9 people, 64.29%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 50.00%
Neoplasm Malignant (cancer tumour): 7 people, 50.00%
Weakness: 1 person, 7.14%
Stress And Anxiety: 1 person, 7.14%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.14%
Neuropathy Peripheral (surface nerve damage): 1 person, 7.14%
Hypotension (abnormally low blood pressure): 1 person, 7.14%
Herpes Zoster: 1 person, 7.14%
Depression: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and have Cellulitis orbital?

- Check whether Cellulitis orbital is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Augmentin:

Augmentin (42,620 reports)

Cellulitis orbital treatments and more:

Cellulitis orbital (779 reports)

How severe was Cellulitis orbital and when was it recovered:

Cellulitis orbital in Augmentin

Expand to all the drugs that have ingredients of amoxicillin; clavulanate potassium:

Cellulitis orbital and drugs with ingredients of amoxicillin; clavulanate potassium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis orbital:

Cellulitis orbital (97 drugs)

Browse all the conditions that are associated with Cellulitis orbital:

Cellulitis orbital (193 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium (the active ingredients of Augmentin) and Augmentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.